Created at Source Raw Value Validated value
June 30, 2022, 4:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: ZyCoV-D - Novel Corona Virus-2019-nCov vaccine of M/s. Zydus Lifesciences Limited: Subject will be administered single dose of 3mg once during the study. 3mg dose of ZyCoVD consists of 3 shots of 0.1ml each via intradermal route using Pharmajet Tropis device at three different sites on the upper arm (2 shots on one arm (recommended distance between two shots is at least 5 cms) and 1 shot on other arm)Control Intervention1: Covaxin of M/s Bharat BiotechBharat Biotech International Ltd.: Subjects will receive0.5ml dose of Covaxin by intramuscular route in upper arm. Subjects will be given one dose only during the study.Control Intervention2: Covishield of M/s Serum Institute ofIndia Pvt. Ltd.: Subjects will receive 0.5ml dose of Covishield by intramuscular route in upper arm. Subjects will be given one dose only during the study", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: ZyCoV-D - Novel Corona Virus-2019-nCov vaccine of M/s. Zydus Lifesciences Limited: Subject will be administered single dose of 3mg once during the study. 3mg dose of ZyCoVD consists of 3 shots of 0.1ml each via intradermal route using Pharmajet Tropis device at three different sites on the upper arm (2 shots on one arm (recommended distance between two shots is at least 5 cms) and 1 shot on other arm)Control Intervention1: Covaxin of M/s Bharat BiotechBharat Biotech International Ltd.: Subjects will receive0.5ml dose of Covaxin by intramuscular route in upper arm. Subjects will be given one dose only during the study.Control", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Covaxin of M/s Bharat BiotechBharat Biotech International Ltd.: Subjects will receive0.5ml dose of Covaxin by intramuscular route in upper arm. Subjects will be given one dose only during the study.Control Intervention2: Covishield of M/s Serum Institute ofIndia Pvt. Ltd.: Subjects will receive 0.5ml dose of Covishield by intramuscular route in upper arm. Subjects will be given one dose only during the study", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1387, "treatment_name": "Covaxin", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 1400, "treatment_name": "Zycov-d", "treatment_type": "Dna based vaccine", "pharmacological_treatment": "Vaccine"}]